Xylometazoline Hydrochloride/Sodium Cromoglicate
盐酸赛洛唑啉/色甘酸钠
Report date: 2022/03/23 14:31:32
NME
Base Information
Drug NameXylometazoline Hydrochloride/Sodium Cromoglicate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes Xylometazoline HydrochlorideSodium Cromoglicate
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesFisons Corp
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBeijing Huaxi United Technology Development Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A